Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...
Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...
Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.
(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...
The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...
Americans 65 and older have Alzheimer’s, which is why it’s so important for us to have tips and tricks for keeping them safe ...
Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...
I spent four crazy years writing about Cassava Sciences. Yesterday, the story ended exactly as I and many others knew it ...
Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...
The Alzheimer’s Foundation of America is offering tips to help those traveling with a loved one with a dementia-related ...
ScienceAlert on MSN1d
Nasal Spray May Slow Alzheimer's Disease, Study in Mice SuggestsThe active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback